VERU INC. Lease Obligation Incurred
VERU INC. (VERU) reported Lease Obligation Incurred of $43.57 thousand for the 12-month period ending 2019-09-30, per its 10-K filed 2019-12-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalLeaseObligationsIncurred · last filed 2019-12-12
- VERU INC. lease obligation incurred for fiscal 2019 was $43.57K.
- VERU INC. lease obligation incurred for fiscal 2009 was $45.81K.
| Period end | Lease Obligation Incurred 12 month |
|---|---|
| 2019-09-30 | $43.57K 10-K · filed 2019-12-12 |
| 2009-09-30 | $45.81K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |